Shionogi & Co. (SGIOY)
(Delayed Data from OTC)
$11.50 USD
+0.10 (0.83%)
Updated Aug 23, 2024 03:56 PM ET
3-Hold of 5 3
B Value D Growth B Momentum B VGM
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$12.00 | $12.00 | $12.00 | 5.26% |
Price Target
Only one analyst offered a short-term price target of $12.00 for Shionogi & Co., Ltd. Unsponsored ADR. This represents an increase of 5.26% from the last closing price of $11.40.
Analyst Price Targets (1 )
Broker Rating
Shionogi & Co., Ltd. Unsponsored ADR currently has an average brokerage recommendation (ABR) of 2.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 2.20 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, three are Strong Buy, representing 60% of all recommendations. A month ago, Strong Buy represented 60%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/SGIOY.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.20 | 2.20 | 2.20 | 2.20 | 2.20 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/11/2024 | Not Identified | Not Identified | Hold | Hold |
2/28/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
12/4/2023 | Goldman Sachs | Akinori Ueda | Not Available | Strong Buy |
10/17/2023 | Not Identified | Not Identified | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.20 |
ABR (Last week) | 2.20 |
# of Recs in ABR | 5 |
Average Target Price | $12.00 |
LT Growth Rate | 4.90% |
Industry | Medical - Drugs |
Industry Rank by ABR | 96 of 253 |
Current Quarter EPS Est: | NA |